Will Lewis, Insmed CEO, joins ‘Fast Money’ to discuss the company’s lung drug being greenlit by the FDA and what it means for for the stock.
Insmed CEO on what’s next for company after FDA greenlights lung disease drug
Related posts
-
Trump-Xi Summit in Focus After Positive US-China Talks
Bloomberg TelevisionMon, September 21, 2026 10:42amURL:Embed:US and Chinese officials offered upbeat assessments of their talks on... -
Germany’s Merz Vows to Stay After Record Election Loss
Bloomberg TelevisionMon, September 21, 2026 10:42amURL:Embed:Friedrich Merz said he would remain as German chancellor after his... -
Fed raises rates for the first time in 3 years
Yahoo FinanceMon, September 21, 2026 10:42amURL:Embed:Kevin Warsh wasted little time with his first interest rate hike...